Tue, Jul 22, 2014, 6:27 AM EDT - U.S. Markets open in 3 hrs 3 mins

Recent

% | $
Click the to save as a favorite.

Healthcare

  • When Ed Owens left her in charge of the Vanguard Health Care Fund (VGHCX) he had run since 1984, it was the single best-performing stock fund over that period, with annualized returns of 16.3%. Hynes had spent 15 years working for Owens at Wellington Management, the Boston-based firm that oversees the fund for Vanguar …

  • Did the FDA go out of its way expose generic drug makers to vastly increased liability?

  • Nurses Shift, Aiming for More Time With Patients @ The Wall Street Journal - 20 minutes ago

    Hospitals hope added face time and personal attention in the patient's room will help make recovery easier.

  • The management of Merck (NYSE: MRK ) is trying a different strategy now. It is trying to work backwards by re-launching previously recalled drugs from the market along with discovering new drugs. However, ...

  • AstraZeneca is casting its net wider in the hot cancer immunotherapy field through a clinical trial collaboration with U.S. biotech firm Advaxis that will test drugs from both companies in combination. ...

  • [$$] Actelion Lifts Guidance as Profit Rises @ The Wall Street Journal - 4 hours ago

    Actelion's sales of a new drug helped push core earnings up by more than a quarter in the first half, a performance that prompted Europe's biggest biotech to raise its guidance for the year.

  • Actelion Ltd. (ATLN) raised its full-year profit forecast after reporting second-quarter earnings that beat analysts’ expectations because of sales of the new lung drug Opsumit. Core earnings will increase at least in the mid-teen percentage range this year, compared with a previous forecast for growth in a low single-digit …

  • Jean-Paul Clozel, CEO of Actelion, says its new drug Opsumit will be a strong driver of growth for the company.

  • [$$] Hospitals, Workers Set Four-Year Agreement @ The Wall Street Journal - 5 hours ago

    Hospitals and 70,000 health-care workers and nurses in the New York City area reached a deal that will avert a strike but doesn't fully resolve the question of whether jobs in a growing number of outpatient ...

  • [$$] Accommodating Both Health and Conscience @ The Wall Street Journal - 5 hours ago

    The best approach is for employers who oppose contraception to instead fund independently administered health savings accounts (HSAs) or health reimbursement arrangements (HRAs) for their employees.

  • [$$] Doctors Upset Over Skill Reviews @ The Wall Street Journal - 5 hours ago

    The medical community is embroiled in a bitter debate about what board-certified physicians should be required to do to prove that their knowledge and skills are up-to-date.

  • * Next step to study Celgene drug with experimental vaccine LONDON, July 22 (Reuters) - An anti-cancer drug made by the U.S. biotech firm Celgene can re-activate hidden HIV in patients so that it can be detected, bringing researchers closer to being able to treat it, Danish scientists said on Tuesday. "There is still …

  • A federal judge ruled on Monday in favor of two tobacco companies that challenged a 2011 U.S. Food and Drug Administration committee report on menthol cigarettes, finding three of the panel's members had conflicts of interests. U.S. District Court Judge Richard Leon ordered the FDA reconstitute the committee and barred …

  • Kindred Healthcare Inc said it is prepared to buy Gentiva Health Services Inc for $17.25 per share, matching an offer by an unnamed party last week. Gentiva shares were marginally up at $18 after markets closed on Monday. Kindred could make a raised offer if it was permitted to conduct diligence, the hospital operator …

  • Gentiva Health announces receipt of acquisition proposal from Kindred Healthcare

  • Kindred Healthcare Inc. (KND) , a long-term medical care provider, raised its bid for Gentiva Health Services Inc. (GTIV), adding fuel to a bidding war for the home-care and hospice company. Kindred offered $17.25 a share in cash, the company said in a letter today to Gentiva’s board, matching the amount proposed by an …

  • Kindred Healthcare Inc said it is prepared to buy Gentiva Health Services Inc for $17.25 per share, matching an offer by an unnamed party last week. Gentiva shares were marginally up at $18 after markets closed on Monday. Kindred can make a raised offer if it was permitted to conduct diligence, the hospital operator said …

  • J&J buying back $5 billion worth of its shares Associated Press - 12 hours ago

    Johnson & Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock. The maker of prescription drugs, medical devices and Tylenol said ...

  • Final Glance: Biotechnology companies Associated Press - 12 hours ago

    Shares of some top biotechnology companies were mixed at the close of trading: Amgen Inc. rose $.73 or .6 percent, to $119.03. Biogen Idec fell $1.60 or .5 percent, to $302.50. Celgene Corp. rose $.25 ...

  • Final Glance: Pharmaceuticals companies Associated Press - 12 hours ago

    Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter International Inc. fell $.41 or .5 percent, to $76.11. Bristol-Myers Squibb Co. fell $.20 or .4 percent, to $48.92. ...

  • Final Glance: Health Care Equipment companies Associated Press - 12 hours ago

    Shares of some top health care equipment companies were mixed at the close of trading: Becton, Dickinson & Co. fell $.77 or .6 percent, to $117.84. Covidien unchanged at $88.53. Patterson rose $.16 or ...

  • Final Glance: Medical Devices companies Associated Press - 12 hours ago

    Shares of some top medical devices companies were mixed at the close of trading: Allergan rose $3.74 or 2.2 percent, to $171.14. Baxter International Inc. fell $.41 or .5 percent, to $76.11. Boston Scientific ...

  • Final Glance: Managed Care companies Associated Press - 12 hours ago

    Shares of some top managed care companies were mixed at the close of trading: Aetna fell $.65 or .8 percent, to $83.99. Cigna Corp. fell $.79 or .8 percent, to $95.53. Humana Inc. rose $.42 or .3 percent, ...

  • Final Glance: Drug Benefits companies Associated Press - 12 hours ago

    Shares of some top drug benefits companies were down at the close of trading: CVSCaremark fell $.43 or .6 percent, to $77.04. Express Scripts Holding Co. fell $.26 or .4 percent, to $65.74.

  • [$$] J&J Adds $5 Billion to Stock Buyback Program @ The Wall Street Journal - 12 hours ago

    Johnson & Johnson said its board approved an additional $5 billion in stock buybacks.

  • Isis Pharmaceuticals, Inc. (ISIS) initiated a phase II study on ISIS-APO(a) in patients suffering from high lipoprotein(a) -- Lp(a).

  • Intuitive Surgical (ISRG) faces the risk of adoption of its procedures as well as risk of lower capital spending by hospitals

  • NPS Pharmaceuticals (NASDAQ: NPSP ) is a biopharmaceutical that focuses on developing best-in-class therapies for extremely rare diseases that would otherwise not garner much attention from other competitors. ...

  • SAN FRANCISCO (MarketWatch) -- Healthcare giant Johnson & Johnson announced late Monday the company's board has approved a $5 billion buyback program of its common stock. Timing of the buybacks is open ...

  • CNBC's Dominic Chu reports Johnson & Johnson has announced a new $5 billion stock buyback program.

  • Sovaldi beat analyst expectations last quarter -- could it again?

  • Johnson & Johnson has an interesting opportunity with the insurance overhaul.

  • Amarin (NASDAQ: AMRN ) president and chief executive officer, John Thero has a performance history predicated on poor decision-making. He's been instrumental in bringing the company and perhaps the most ...

  • Don't chase yield if it means settling for a company with substandard growth.

  • Inefficient Market Theory suggests that a company's market capitalization is not always a true reflection of its value, and it can be vastly different than the current value of their future cash flows....

  • Investigators say overloaded bins caused collapse

    Overloaded storage bins on the roof of an Omaha livestock feed manufacturer's plant caused the building collapse that killed two people in January, federal investigators said Monday. International Nutrition ...

  • Following the news, Thermo Fisher's (TMO) share price gained 1.7% to eventually close at $121.00 on Friday.

  • Biogen Shares Rebound As Street Has A Change Of Heart @ Investor's Business Daily - 14 hours ago

    Biogen Idec heads into its second-quarter earnings report on one of its best rolls in years, as the biotech continues to benefit from heavy demand for its drugs to treat multiple sclerosis, cancer and ...

  • Under-Promising and Over-Delivering: Why Allergan Is a Buy @ Wall St. Cheat Sheet - 14 hours ago

    Given that Allergan has high demand products and solid management, the company continues to absolutely deliver.

  • AbbVie Inc. could realize up to $8 billion in tax breaks over the next 15 years as a result of its merger with Shire PLC, and it may need them, a report says.

  • Alkermes (ALKS) announced the commencement of a phase I study on ALKS 8700.

  • Astellas Pharma, Inc. (ALPMY) provided a comprehensive overview of its initiatives towards innovation, research and development and its corporate strategy.

  • Nobody thinks it's possible Gilead can sell off, bit it can. I dispel the hype and go short.

  • Why Your MRI or CT Scan Costs an Arm and a Leg The Fiscal Times - 15 hours ago
    Why Your MRI or CT Scan Costs an Arm and a Leg

    Medical imaging is one of the most common and overused diagnostic techniques used today, and by far the costliest. While cancer caused by radiation from medical imaging can be a long-term concern, the more immediate worry for someone facing a new diagnosis is usually cost. The good news is that there are at least a few …

  • Athenahealth posted solid sales growth in the second quarter as it won share from Allscripts and Quality Systems, but investors are right to worry over lackluster earnings.

  • Pfizer's Stock Falls Ill as the Dow Tumbles @ Motley Fool - 15 hours ago

    AbbVie's stock falls after its market-shaking deal to acquire Shire on Friday.

  • The death toll is rising in the Middle East as a hospital in Gaza City was hit. NBC's Ayman Mohyeldin reports hospitals in the region do not have the basic needs to meet the demands of the people.

  • Welcome to Ireland, AbbVie @ Motley Fool - 16 hours ago

    AbbVie paid a whopping $54.8 billion for Shire, but it's a good deal--assuming the U.S. Congress doesn't pass a law undercutting the tax gains.

  • Boston Scientific Corporation (BSX) is scheduled to report its second-quarter 2014 results before the opening bell on Jul 24.

  • Investors in biotechnology stocks, including myself, are always trying to balance risk and reward when purchasing stocks in this highly volatile sector. Having a biomedical Ph.D., I spend endless hours ...

Next >>
Next >>